Eliem Therapeutics, Inc. (ELYM): Price and Financial Metrics

Eliem Therapeutics, Inc. (ELYM): $5.11

0.05 (-0.97%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add ELYM to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#155 of 337

in industry

ELYM Price/Volume Stats

Current price $5.11 52-week high $11.55
Prev. close $5.16 52-week low $2.35
Day low $5.00 Volume 803,900
Day high $5.26 Avg. volume 486,688
50-day MA $6.97 Dividend yield N/A
200-day MA $5.38 Market Cap 152.03M

ELYM Stock Price Chart Interactive Chart >


Eliem Therapeutics, Inc. (ELYM) Company Bio


Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy, and other disorders of the peripheral and central nervous systems in the United States. The company's lead clinical-stage candidates include ETX-810, a novel palmitoylethanolamide prodrug that is in Phase IIa clinical trials for the treatment of diabetic peripheral neuropathic pain and pain associated with lumbosacral radiculopathy; and ETX-155 is a neurosteroid GABAA receptor positive allosteric modulator for the treatment of major depressive disorder, perimenopausal depression, and focal onset seizures. Its lead preclinical program includes Kv7.2/3 potassium channel opener for epilepsy and pain; and novel analog of 2,3- benzodiazepine for the treatment of generalized anxiety disorder. The company was incorporated in 2018 and is headquartered in Redmond, Washington.


ELYM Latest News Stream


Event/Time News Detail
Loading, please wait...

ELYM Latest Social Stream


Loading social stream, please wait...

View Full ELYM Social Stream

ELYM Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!